First Eagle Investment Management LLC grew its position in ZimVie Inc. (NASDAQ:ZIMV – Free Report) by 33.6% during the fourth quarter, Holdings Channel reports. The firm owned 267,971 shares of the company’s stock after acquiring an additional 67,400 shares during the period. First Eagle Investment Management LLC’s holdings in ZimVie were worth $3,738,000 as of its most recent filing with the SEC.
Other hedge funds have also modified their holdings of the company. Geode Capital Management LLC boosted its stake in shares of ZimVie by 2.4% in the third quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock worth $10,263,000 after buying an additional 15,053 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in shares of ZimVie by 1.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 398,306 shares of the company’s stock worth $6,321,000 after buying an additional 6,235 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of ZimVie by 66.7% in the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock worth $2,911,000 after buying an additional 73,395 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of ZimVie by 0.9% in the fourth quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock worth $1,404,000 after buying an additional 943 shares during the last quarter. Finally, Monarch Capital Management Inc. boosted its stake in shares of ZimVie by 6.2% in the fourth quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company’s stock worth $915,000 after buying an additional 3,847 shares during the last quarter. 95.63% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research note on Thursday.
ZimVie Stock Up 0.5 %
Shares of ZIMV opened at $12.04 on Friday. The company has a market capitalization of $333.23 million, a price-to-earnings ratio of -0.92 and a beta of 2.10. The stock’s 50-day moving average price is $13.50 and its 200-day moving average price is $14.40. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 52 week low of $11.62 and a 52 week high of $22.40.
ZimVie (NASDAQ:ZIMV – Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.02. The company had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. On average, sell-side analysts predict that ZimVie Inc. will post 0.6 EPS for the current year.
ZimVie Company Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Further Reading
- Five stocks we like better than ZimVie
- How to trade penny stocks: A step-by-step guide
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is a SEC Filing?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Stock Dividend Cuts Happen Are You Ready?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMV – Free Report).
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.